These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 21185506

  • 1. Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease.
    Printz BF, Sleeper LA, Newburger JW, Minich LL, Bradley T, Cohen MS, Frank D, Li JS, Margossian R, Shirali G, Takahashi M, Colan SD, Pediatric Heart Network Investigators.
    J Am Coll Cardiol; 2011 Jan 04; 57(1):86-92. PubMed ID: 21185506
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Association of left ventricular systolic dysfunction with coronary artery dilation in Kawasaki disease patients: Assessment with cardiovascular magnetic resonance.
    Zhou ZQ, Wen LY, Fu C, Yang Z, Fu H, Xu R, Zhang L, Xu K, Zhou B, Shi XQ, Guo YK.
    Eur J Radiol; 2021 Dec 04; 145():110039. PubMed ID: 34818610
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Echo-Doppler assessment of arterial stiffness in pediatric patients with Kawasaki disease.
    AlHuzaimi A, Al Mashham Y, Potts JE, De Souza AM, Sandor GG.
    J Am Soc Echocardiogr; 2013 Sep 04; 26(9):1084-9. PubMed ID: 23800509
    [Abstract] [Full Text] [Related]

  • 13. Risk factors and implications of progressive coronary dilatation in children with Kawasaki disease.
    Liu MY, Liu HM, Wu CH, Chang CH, Huang GJ, Chen CA, Chiu SN, Lu CW, Lin MT, Chang LY, Wang JK, Wu MH.
    BMC Pediatr; 2017 Jun 06; 17(1):139. PubMed ID: 28587647
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease].
    Peng Q, Zhou TF, Chen CH, Hua YM, Liu HM, Hong H, Zhang LY, Wu Q.
    Zhonghua Er Ke Za Zhi; 2005 Sep 06; 43(9):676-80. PubMed ID: 16191301
    [Abstract] [Full Text] [Related]

  • 17. Usefulness of echocardiographic evidence of pericardial effusion and mitral regurgitation during the acute stage in predicting development of coronary arterial aneurysms in the late stage of Kawasaki disease.
    Gidding SS, Duffy CE, Pajcic S, Berdusis K, Shulman ST.
    Am J Cardiol; 1987 Jul 01; 60(1):76-9. PubMed ID: 3604947
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease.
    Kurotobi S, Kawakami N, Shimizu K, Aoki H, Nasuno S, Takahashi K, Kogaki S, Ozono K.
    Pediatr Cardiol; 2005 Jul 01; 26(4):425-30. PubMed ID: 15633045
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.